Concepedia

Michael Ruzicka

MR

6

Publications

251

Citations

6

H-Index

2019

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

LMU Klinikum

German Center for Infection Research

Michael Ruzicka is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2019–2024

6

Publications

6

Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?

Jan‐Niclas Mumm, Andreas Osterman, Michael Ruzicka et al. · European Urology · 2020 · 145 citations · Full text

, , +6

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

Michael Ruzicka, Lars M. Koenig, Simone Formisano et al. · Leukemia · 2019 · 46 citations · Full text

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 22 citations

, , +12

Characterization of cognitive symptoms in post COVID-19 patients

Michael Ruzicka, Simone Sachenbacher, Fides Heimkes et al. · European Archives of Psychiatry and Clinical Neuroscience · 2024 · 14 citations · Full text

Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment

Michael Winkelmann, Veit Bücklein, Viktoria Blumenberg et al. · Frontiers in Oncology · 2022 · 13 citations · Full text

Rows per page

1–5 of 6